Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 22,187 | 135,012 | 2,597 | 0 |
| Operating Income | -22,187 | -135,012 | -2,597 | N/A |
| Interest Expense | 3,358 | 0 | 0 | 0 |
| Other Income | -17,952 | 110 | 0 | 0 |
| Pre-tax Income | -43,497 | -134,902 | -2,597 | 0 |
| Net Income Continuous | -43,497 | -134,902 | -2,597 | N/A |
| Net Income | $-43,497 | $-134,902 | $-2,597 | $N/A |
| EPS Basic Total Ops | -10.71 | -43.82 | -0.10 | N/A |
| EPS Basic Continuous Ops | -10.71 | -43.81 | -0.10 | N/A |
| EPS Diluted Total Ops | -10.71 | -43.82 | -0.10 | N/A |
| EPS Diluted Continuous Ops | -10.71 | -43.81 | -0.10 | N/A |
| EBITDA(a) | $-21,559 | $-135,012 | $-2,597 | $N/A |